BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30796300)

  • 1. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease.
    Karamched SR; Nosoudi N; Moreland HE; Chowdhury A; Vyavahare NR
    Sci Rep; 2019 Feb; 9(1):2629. PubMed ID: 30796300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects.
    Lei Y; Nosoudi N; Vyavahare N
    J Control Release; 2014 Dec; 196():79-86. PubMed ID: 25285609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles.
    Nosoudi N; Chowdhury A; Siclari S; Karamched S; Parasaram V; Parrish J; Gerard P; Vyavahare N
    Theranostics; 2016; 6(11):1975-1987. PubMed ID: 27698934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of reversal of aortic calcification by chelating agents.
    Lei Y; Grover A; Sinha A; Vyavahare N
    Calcif Tissue Int; 2013 Nov; 93(5):426-35. PubMed ID: 23963635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
    Nosoudi N; Nahar-Gohad P; Sinha A; Chowdhury A; Gerard P; Carsten CG; Gray BH; Vyavahare NR
    Circ Res; 2015 Nov; 117(11):e80-9. PubMed ID: 26443597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
    Neven E; Bashir-Dar R; Dams G; Behets GJ; Verhulst A; Elseviers M; D'Haese PC
    J Bone Miner Res; 2015 Dec; 30(12):2313-24. PubMed ID: 26108730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
    Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
    Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
    Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles.
    Keuth J; Nitschke Y; Mulac D; Riehemann K; Rutsch F; Langer K
    Eur J Pharm Biopharm; 2020 May; 150():108-119. PubMed ID: 32151731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
    de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
    Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
    Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
    J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice.
    Marulanda J; Gao C; Roman H; Henderson JE; Murshed M
    Bone; 2013 Dec; 57(2):499-508. PubMed ID: 23994172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC42 promotes vascular calcification in chronic kidney disease.
    Li Z; Wu J; Zhang X; Ou C; Zhong X; Chen Y; Lu L; Liu H; Li Y; Liu X; Wu B; Wang Y; Yang P; Yan J; Chen M
    J Pathol; 2019 Dec; 249(4):461-471. PubMed ID: 31397884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model.
    Tani T; Fujiwara M; Orimo H; Shimizu A; Narisawa S; Pinkerton AB; Millán JL; Tsuruoka S
    J Pathol; 2020 Jan; 250(1):30-41. PubMed ID: 31509234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats.
    Nosoudi N; Chowdhury A; Siclari S; Parasaram V; Karamched S; Vyavahare N
    J Cardiovasc Transl Res; 2016 Dec; 9(5-6):445-455. PubMed ID: 27542007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease.
    Yoshida T; Yamashita M; Horimai C; Hayashi M
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29146611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
    McCabe KM; Booth SL; Fu X; Shobeiri N; Pang JJ; Adams MA; Holden RM
    Kidney Int; 2013 May; 83(5):835-44. PubMed ID: 23344475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.